http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180072326-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ec38905d57b9fda6d35ea26e720f958
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b5f41889212134f724ee94357d02f4b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6937
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
filingDate 2016-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0e3051e6b8673c8825183445abd63e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77171c758c4d93b446d489ab9b09c443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12464d7192588a9fc0854be95badc564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e2e3a8f023a6a5b7cf3394cb89dd79d
publicationDate 2018-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20180072326-A
titleOfInvention Anti-cancer drug Effective for Multidrug resistant cancer cells
abstract The present invention relates to a PLGA nanoparticle loaded with dobutamine and a composition for preventing or treating cancer comprising the same. The PLGA nanoparticles loaded with dobutamine according to the present invention are in the form of a nano emulsion, which remarkably improves solubility and dispersibility in an aqueous solvent, and is excellent in the selective delivery efficiency to cancer cells. In addition, it can be used as a new therapeutic agent for cancer-resistant intractable cancer which has no distinct treatment method, while expanding the application of dobutamine as a cardiovascular treatment agent.
priorityDate 2016-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9920342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477666
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16218600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426152218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447865360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21795220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426254013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426169444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656852
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11046239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451265449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833303
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422966728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415967486

Total number of triples: 47.